US.TMO · Thermo Fisher Scientific

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.8,
      "details": {
        "atrPct": 2.50576754333157,
        "turnoverUsdM": 1167.6677457518,
        "liquidityPoints": 0.8,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.TMO",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 601.9514,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 5,
      "take_profit_price": 670.9205,
      "target_multiplier": 1.9,
      "technical_strength": 1.85,
      "take_profit_percent": 5.9
    },
    "positionPoints": 1.8,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.01153508666314,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 78.6,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 63.6,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 15
  },
  "market": {
    "ma20": 598.4545,
    "ma50": 551.1138,
    "close": 633.71,
    "prevClose": 628.15,
    "avgVolume20": 1773525,
    "volumeRatio": 1.04,
    "changePercent": 0.89
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 15,
    "details": {
      "ret_5d": 0.03287485845665672,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 15,
      "vcp_bonus": 2,
      "vol_ratio": 1.0187175014582015,
      "ret_points": 8,
      "vol_points": 2,
      "range_ratio": 0.8696367201746096,
      "volat_points": 0,
      "day_range_pct": 0.021823890365501867,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 78.6,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.9,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 58,
        "contribution": 2.9
      },
      {
        "raw": 17.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 86,
        "contribution": 17.2
      },
      {
        "raw": 8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 53.33,
        "contribution": 8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 70,
        "contribution": 7
      },
      {
        "raw": 22.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 75,
        "contribution": 22.5
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 63.6,
    "details": [
      "基本面分析總分: 2.9/5分",
      "資金流分析總分: 17.2/20分",
      "市場環境分析總分: 8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7/10分",
      "技術信號分析總分: 22.5/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.9,
      "資金流": 17.2,
      "市場環境": 8,
      "情緒分析": 4,
      "技術信號": 22.5,
      "風險管理": 7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 1167.6677457518,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "優秀",
        "items": {
          "cmfPoints": 4,
          "mfiPoints": 3.2,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.TMO",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.45
            }
          },
          "trend": {
            "score": 1.7999999999999998,
            "details": {
              "qqq": {
                "ma20": 714.64200185,
                "ma50": 712.3606008399998,
                "name": "QQQ",
                "close": 711.37,
                "points": 0.4
              },
              "spy": {
                "ma20": 766.6294981500001,
                "ma50": 752.9720029399998,
                "name": "SPY",
                "close": 766.080017,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.50576754333157,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 1.7999999999999998
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141302750,
                "url": "https://finnhub.io/api/news?id=6572a92e3e41bdcd5edabcb05d4a978b7585b43adaaadc5c9d7187199fbb50a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) is drawing investor attention after completing Olink Explore HT proteomic analysis on about 5,500 samples from The Michael J. Fox Foundation’s Parkinson’s Precision Medicine Initiative. See our latest analysis for Thermo Fisher Scientific. The proteomics update arrives after a strong run in Thermo Fisher Scientific’s stock, with the share price at US$629.27 and a 30 day share price return of 19.53%, alongside a 1 year total shareholder return of 26.32% that...",
                "category": "company",
                "datetime": 1787414965,
                "headline": "Thermo Fisher Scientific (TMO) Could Be Fully Valued On Parkinsons Proteomics Progress"
              },
              {
                "id": 141302748,
                "url": "https://finnhub.io/api/news?id=6dc24ddc63a284560a6e135de26c28cab8b112bf858eb204f1d48a72a995f222",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The latest analyst work on Thermo Fisher Scientific includes a higher Fair Value Estimate that has moved from US$590.77 to US$631.42, a change of about 6.9% that feeds directly into refreshed price targets across coverage. This shift sits against a backdrop of mixed optimism and caution, as analysts weigh Q2 strength, sector updates through 2026, and the balance of growth ambition and execution risks. As you read on, you will see how this evolving narrative could shape the way you track...",
                "category": "company",
                "datetime": 1787407764,
                "headline": "Thermo Fisher Scientific (TMO) Stock Fair Value Rises After Q2 Strength And Analyst Revisions"
              },
              {
                "id": 141302749,
                "url": "https://finnhub.io/api/news?id=f91451998441d418cc2d9aa60636d8b22e4d0e55fe36b0b064b2e35c8431fe12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific stock has delivered a strong 26.3% return over the past year, yet the valuation checks suggest the shares are no longer an obvious bargain. The Discounted Cash Flow (DCF) estimate points to a level that is close to the current price, while market multiples lean richer. Over the past 12 months Thermo Fisher Scientific has returned 26.3%, which puts more pressure on today’s buyers to justify paying up at current levels. Participation in areas such as protein design...",
                "category": "company",
                "datetime": 1787404093,
                "headline": "Thermo Fisher (TMO) Stock Looks Fully Valued Following Its Microbiology Sale"
              },
              {
                "id": 141278732,
                "url": "https://finnhub.io/api/news?id=b7bd12285fc5ecb61151668efdbeab3c1061622131de396f1923e27a0e0a8acc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how research tools & consumables stocks fared in Q2, starting with Thermo Fisher (NYSE:TMO).",
                "category": "company",
                "datetime": 1787148122,
                "headline": "Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks"
              },
              {
                "id": 141200943,
                "url": "https://finnhub.io/api/news?id=f66438eaa277b84a45f4894bded349862307d7516a55a2c5295d417cac93a87d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) mostly sells the instruments and supplies that let other companies do science, not the treatments themselves. So when the company said on July 29 that it had launched the PPD CorEvitas Vitiligo Registry on July 14, to track how patients with nonsegmental vitiligo respond to treatment, it pointed to a quieter […]",
                "category": "company",
                "datetime": 1786483206,
                "headline": "Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?"
              },
              {
                "id": 141177593,
                "url": "https://finnhub.io/api/news?id=5673eef1b4d22935ead2b0f60b3668cc7f178414347c327699ee964157cab081",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "In late July 2026, Thermo Fisher Scientific used the ADLM conference in Anaheim to highlight new FDA-cleared diagnostic platforms, including the EXENT Solution for multiple myeloma and EliA CTD 13 Screen for systemic autoimmune connective tissue diseases, alongside expanded digital and quality-control offerings for clinical laboratories. By pairing these regulatory milestones with integrated software such as LabLink360 and broad biomarker portfolios like B·R·A·H·M·S, Thermo Fisher is...",
                "category": "company",
                "datetime": 1786389308,
                "headline": "How Investors Are Reacting To Thermo Fisher Scientific (TMO) New FDA-Cleared Multiple Myeloma Platform"
              },
              {
                "id": 141170762,
                "url": "https://finnhub.io/api/news?id=6b9a3f1775af4dab94d6e3c7773120703ca790f7fe5828a80bb0233bab391613",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher Corporation (NYSE:DHR) are two of the world’s largest life sciences tools companies, making them natural competitors for investors looking to capitalize on a recovery in pharmaceutical and biotechnology research spending. Both companies delivered better-than-expected second-quarter results, but while Thermo Fisher (NYSE:TMO) raised guidance on broad-based demand improvement, Danaher’s […]",
                "category": "company",
                "datetime": 1786320091,
                "headline": "Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?"
              },
              {
                "id": 141100875,
                "url": "https://finnhub.io/api/news?id=f3f4d21a89aa82427dddec50d1979ffdcf38762ace0db69ee484a8c55eb94ce4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Examine the evolution of Thermo Fisher's (TMO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.",
                "category": "company",
                "datetime": 1785762903,
                "headline": "Unlocking Thermo Fisher (TMO) International Revenues: Trends, Surprises, and Prospects"
              }
            ],
            "raw_source": [
              {
                "id": 141323340,
                "url": "https://finnhub.io/api/news?id=086f3262638df573fb45205a3b3a72b809ad82570ca30648c34ff55b83f0c775",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/26/Delta-Air-Lines-Jet-Overturns-At-Toronto.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Experts recommend Delta, Thermo Fisher, Target, and Interactive Brokers Group, Inc. due to strong earnings and guidance.",
                "category": "company",
                "datetime": 1787728265,
                "headline": "Delta Air, Target, Thermo Fisher Scientific And A Financial Stock On CNBC’s ‘Final Trades’"
              },
              {
                "id": 141309202,
                "url": "https://finnhub.io/api/news?id=64dca95cbecb10e25587e1b04ef31b6887f8b6c89f2314e64cde9afd73704d4f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2291295850/image_2291295850.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Treasury Secretary Scott Bessent could tap the Treasury's almost $1T General Account to help fund increased purchases of long-dated government bonds, CNBC reported.",
                "category": "company",
                "datetime": 1787572860,
                "headline": "Wall Street Lunch: Bessent Floats $1T Treasury Firepower"
              },
              {
                "id": 141302750,
                "url": "https://finnhub.io/api/news?id=6572a92e3e41bdcd5edabcb05d4a978b7585b43adaaadc5c9d7187199fbb50a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) is drawing investor attention after completing Olink Explore HT proteomic analysis on about 5,500 samples from The Michael J. Fox Foundation’s Parkinson’s Precision Medicine Initiative. See our latest analysis for Thermo Fisher Scientific. The proteomics update arrives after a strong run in Thermo Fisher Scientific’s stock, with the share price at US$629.27 and a 30 day share price return of 19.53%, alongside a 1 year total shareholder return of 26.32% that...",
                "category": "company",
                "datetime": 1787414965,
                "headline": "Thermo Fisher Scientific (TMO) Could Be Fully Valued On Parkinsons Proteomics Progress"
              },
              {
                "id": 141302748,
                "url": "https://finnhub.io/api/news?id=6dc24ddc63a284560a6e135de26c28cab8b112bf858eb204f1d48a72a995f222",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The latest analyst work on Thermo Fisher Scientific includes a higher Fair Value Estimate that has moved from US$590.77 to US$631.42, a change of about 6.9% that feeds directly into refreshed price targets across coverage. This shift sits against a backdrop of mixed optimism and caution, as analysts weigh Q2 strength, sector updates through 2026, and the balance of growth ambition and execution risks. As you read on, you will see how this evolving narrative could shape the way you track...",
                "category": "company",
                "datetime": 1787407764,
                "headline": "Thermo Fisher Scientific (TMO) Stock Fair Value Rises After Q2 Strength And Analyst Revisions"
              },
              {
                "id": 141302749,
                "url": "https://finnhub.io/api/news?id=f91451998441d418cc2d9aa60636d8b22e4d0e55fe36b0b064b2e35c8431fe12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific stock has delivered a strong 26.3% return over the past year, yet the valuation checks suggest the shares are no longer an obvious bargain. The Discounted Cash Flow (DCF) estimate points to a level that is close to the current price, while market multiples lean richer. Over the past 12 months Thermo Fisher Scientific has returned 26.3%, which puts more pressure on today’s buyers to justify paying up at current levels. Participation in areas such as protein design...",
                "category": "company",
                "datetime": 1787404093,
                "headline": "Thermo Fisher (TMO) Stock Looks Fully Valued Following Its Microbiology Sale"
              },
              {
                "id": 141278739,
                "url": "https://finnhub.io/api/news?id=a5c947171d3000651ec7a3b3df3ccb64db3ec85dec18db10d5870739d886c511",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Agilent Technologies has a company-confirmed earnings report dropping after the close on August 26, and every operating lever heading into that date is pointing the same direction. Here is what retirement-focused investors need to understand before the bell rings.",
                "category": "company",
                "datetime": 1787324445,
                "headline": "Agilent Stock Has A Catalyst Coming On August 26 That Investors Should Not Ignore"
              },
              {
                "id": 141278418,
                "url": "https://finnhub.io/api/news?id=14fca526c0005a2e54535a057914bc5cc07c743197784d940f83e1cfc6ec3e95",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Former General Electric and Thermo Fisher Scientific counsel Jonas Svedlund will oversee the carrier’s legal and compliance functions.",
                "category": "company",
                "datetime": 1787310900,
                "headline": "XPO names chief legal officer"
              },
              {
                "id": 141278740,
                "url": "https://finnhub.io/api/news?id=4f593bb4d42bf16578459f9d70d79028fa76058867ca56c48c0a33c0ac12de5e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "BIO's 19.1% monthly rally is backed by digital PCR gains and steadier diagnostics, but weak Life Science demand and a rich valuation loom.",
                "category": "company",
                "datetime": 1787242980,
                "headline": "Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building?"
              },
              {
                "id": 141264457,
                "url": "https://finnhub.io/api/news?id=0f35252255458197d640a9a6e84e4d446dab53e84ac4b4f95fe5bd54531381f7",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/20/Paris--France---June-16--2023-Elon-Musk-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Elon Musk said mRNA could fundamentally change disease treatment, turning medicine into a software problem.",
                "category": "company",
                "datetime": 1787213910,
                "headline": "Elon Musk Says mRNA Has ‘Tremendous’ Potential After Moderna, Merck Cancer Vaccine Breakthrough — MRNA Stock Falls Over 11% in Premarket (UPDATED)"
              },
              {
                "id": 141278737,
                "url": "https://finnhub.io/api/news?id=67621dd00d7b4422294b7c05c38a9ef3f25ba0e393e2e079e5179b2aacf01c1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Opportunities span AI-driven protein design and structure prediction, precision therapeutics, engineered biologics and vaccines, synthetic biology, novel enzymes, high-throughput screening, and advanced computational modeling, with Asia-Pacific offering expansion potential. Protein Design and Engineering Market Protein Design and Engineering Market Dublin, Aug. 19, 2026 (GLOBE NEWSWIRE) -- The \"Protein Design and Engineering Market Global Report 2026\" has been added to ResearchAndMarkets.com's o",
                "category": "company",
                "datetime": 1787153280,
                "headline": "Protein Design & Engineering Market Global Report 2026: Evaluating AI Platforms, Rational Design, Directed Evolution, and Strategies of Lonza, Thermo Fisher, GenScript, and Charles River"
              },
              {
                "id": 141266867,
                "url": "https://finnhub.io/api/news?id=9ac04e066b2b89b0fc3c8cc452cb4f1eac98134d4dbc5dfd4c146140b24123fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "ABT's Medical Devices growth is fueled by electrophysiology, expanding CGM adoption and a cardiovascular pipeline extending into 2029 and beyond.",
                "category": "company",
                "datetime": 1787152020,
                "headline": "Here's How Abbott's Medical Devices Arm Acts as a Growth Catalyst"
              },
              {
                "id": 141278732,
                "url": "https://finnhub.io/api/news?id=b7bd12285fc5ecb61151668efdbeab3c1061622131de396f1923e27a0e0a8acc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how research tools & consumables stocks fared in Q2, starting with Thermo Fisher (NYSE:TMO).",
                "category": "company",
                "datetime": 1787148122,
                "headline": "Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks"
              },
              {
                "id": 141250811,
                "url": "https://finnhub.io/api/news?id=9d71a11ac50f796cfd2586dab3cdda355e745abc81ec1890055606c493633591",
                "image": "",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "",
                "category": "company",
                "datetime": 1787091773,
                "headline": "Tracking Al Gore's Generation Investment Management Portfolio - Q2 2026 Update"
              },
              {
                "id": 141278742,
                "url": "https://finnhub.io/api/news?id=e7e7f7a6a725027dd5628f6a57a2818d1e6e728af5250c3bf4fb2c6880f69905",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
                "category": "company",
                "datetime": 1787059293,
                "headline": "3 S&P 500 Stocks with Open Questions"
              },
              {
                "id": 141278747,
                "url": "https://finnhub.io/api/news?id=19646b206032bf733f37af72dbba753c73fa3124f090524d2a01763b53b3832d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "QuidelOrtho's 31.7% three-month rally meets resilient core growth and cost savings, but China weakness, lower guidance and high debt cloud further gains.",
                "category": "company",
                "datetime": 1786992360,
                "headline": "QDEL Rallies 31.7% in Three Months: Can the Stock Keep Climbing Higher?"
              },
              {
                "id": 141278733,
                "url": "https://finnhub.io/api/news?id=fe07e930497fb07ba5730dfb40d73545854ab6f703558684b2354123e3469ea6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.",
                "category": "company",
                "datetime": 1786980689,
                "headline": "Thermo Fisher Scientific Stock: Analyst Estimates & Ratings"
              },
              {
                "id": 141278743,
                "url": "https://finnhub.io/api/news?id=3751aa2c0478dc7677521e525f42a5578d2556842ca914766274eb193bbfdc4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "PTC Therapeutics (NASDAQ:PTCT) plans to acquire the ST-920 Fabry disease gene therapy asset through a competitive bankruptcy auction, positioning the company to add a potential one-time treatment to its rare disease portfolio while using its existing global commercial and regulatory infrastructure.",
                "category": "company",
                "datetime": 1786896114,
                "headline": "PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal"
              },
              {
                "id": 141230562,
                "url": "https://finnhub.io/api/news?id=4d092ebe3aa6f83822c04a961bb022d30ba76830344f6c5fdbe0e95de91c9b2a",
                "image": "",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "",
                "category": "company",
                "datetime": 1786857318,
                "headline": "Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside"
              },
              {
                "id": 141278744,
                "url": "https://finnhub.io/api/news?id=b64ebc7a931ed7df30857236214f868813c07be1b2f8ad028cf42d29626250f1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.",
                "category": "company",
                "datetime": 1786837500,
                "headline": "3 Profitable Stocks We’re Skeptical Of"
              },
              {
                "id": 141218677,
                "url": "https://finnhub.io/api/news?id=652224e6eaeca65523b7fcc05076da4b572b7f65213dd09624d1398b823f11df",
                "image": "",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "",
                "category": "company",
                "datetime": 1786721166,
                "headline": "Danaher: 2027 Growth Reacceleration Should Drive Upside"
              },
              {
                "id": 141215052,
                "url": "https://finnhub.io/api/news?id=0176a51efbd17552a021ae81e4d6bc2b237153c9b5d85da75207c1b8fc338ef7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Senior Thermo Fisher Scientific executive brings nearly 30 years of healthcare and commercial leadership to support Envetec’s global expansion Patrick S. Jones Patrick S. Jones, President of Thermo Fisher Scientific’s Clinical Diagnostics Division and independent director of Envetec Sustainable Technologies BIRDHILL, Ireland, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Envetec Sustainable Technologies Limited (Envetec), a leading sustainability innovator in clean technology for healthcare and life science",
                "category": "company",
                "datetime": 1786690800,
                "headline": "Envetec Appoints Patrick S. Jones as Independent Director"
              },
              {
                "id": 141208038,
                "url": "https://finnhub.io/api/news?id=c8bcf0ee43232416974e444c297c4000449109a83a8108cf766fba36d8db622a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "European private equity firm Astorg will run the business as an independent diagnostics company, led by former PerkinElmer CEO Dirk Bontridder.",
                "category": "company",
                "datetime": 1786619968,
                "headline": "Thermo Fisher closes $1.1B sale of microbiology unit to PE firm"
              },
              {
                "id": 141203650,
                "url": "https://finnhub.io/api/news?id=4d5de86f126d470d2f229dffe7444b62a75213e96f560786a24d960fae237ac4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "LivaNova PLC recently reported second-quarter 2026 results showing sales rising to US$390.59 million and net income climbing to US$108.57 million, alongside higher earnings per share versus a year earlier. On the back of this performance, the company raised its 2026 constant-currency revenue growth guidance to a range of 8% to 9% and secured a long-term oxygenator supply agreement with Thermo Fisher Scientific to support manufacturing expansion. Now we’ll examine how the raised 2026 growth...",
                "category": "company",
                "datetime": 1786576597,
                "headline": "Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN)"
              },
              {
                "id": 141203651,
                "url": "https://finnhub.io/api/news?id=c0c058b308c8596f720000900af5beb5fe1d492b5330e21eb98a5a6ef975c725",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "LivaNova (LIVN) raised its full year 2026 revenue and earnings guidance after reporting record quarterly revenue and significantly higher profitability, supported by demand for its Essenz heart-lung machine and a new supply agreement with Thermo Fisher Scientific. See our latest analysis for LivaNova. LivaNova's recent guidance lift comes after a strong run in the share price, with a 90 day share price return of 12.71% and a year to date share price return of 33.21%. The 1 year total...",
                "category": "company",
                "datetime": 1786572592,
                "headline": "LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance"
              },
              {
                "id": 141200939,
                "url": "https://finnhub.io/api/news?id=bd785490179cd2145e424c9b579f44f31786f21fc5df1c0cef94108440c77c85",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "LUXEMBOURG & NEW YORK & PARIS, August 12, 2026--Astorg, a leading pan-European private equity firm, today announced the successful completion of its acquisition of the global microbiology business from Thermo Fisher Scientific. The business will now operate as an independent company under the leadership of Chief Executive Officer Dirk Bontridder and will launch under a new corporate brand later in 2026.",
                "category": "company",
                "datetime": 1786536600,
                "headline": "Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist"
              },
              {
                "id": 141200941,
                "url": "https://finnhub.io/api/news?id=b1f12e83ca42c474087a59f08c346969d87ef9b4ed4f0882dd05522ecd60ba3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "WALTHAM, Mass., August 12, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note.",
                "category": "company",
                "datetime": 1786536000,
                "headline": "Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg"
              },
              {
                "id": 141200944,
                "url": "https://finnhub.io/api/news?id=3b447c99f68999cfd97d10c962b5d5dac069cdcc6abea5f60eb2ceeaa87d2eb5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Accelerating momentum across major industry heavyweights—highlighted by Thermo Fisher Scientific’s Q2 2026 revenue beat, Hamamatsu Photonics’ launch of its dedicated Lasers & Fibers Business Unit, and BD’s $4.98 billion Q3 performance—is driving rapid adoption of optical diagnostic and imaging solutions worldwide. This report provides an in-depth analysis of key technological advancements, regional market shares, and competitive strategies across the global biophotonics sector. Biophotonics Mark",
                "category": "company",
                "datetime": 1786533600,
                "headline": "Following Hamamatsu's Rebranding of NKT Photonics to Drive Laser Innovation, New Biophotonics Market Overview Maps Strategic Growth Through 2030"
              },
              {
                "id": 141200942,
                "url": "https://finnhub.io/api/news?id=43ac900446deda61745614e800236fd050b4c546db7858fa9c2cd3757d1056b4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Arcturus Therapeutics (NASDAQ:ARCT) is positioning its mRNA platform around two rare-disease programs targeting cystic fibrosis and ornithine transcarbamylase deficiency, while its vaccine business is intended to help support therapeutic development, President and CEO Joseph Payne said during a Cana",
                "category": "company",
                "datetime": 1786496653,
                "headline": "Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline"
              },
              {
                "id": 141200943,
                "url": "https://finnhub.io/api/news?id=f66438eaa277b84a45f4894bded349862307d7516a55a2c5295d417cac93a87d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) mostly sells the instruments and supplies that let other companies do science, not the treatments themselves. So when the company said on July 29 that it had launched the PPD CorEvitas Vitiligo Registry on July 14, to track how patients with nonsegmental vitiligo respond to treatment, it pointed to a quieter […]",
                "category": "company",
                "datetime": 1786483206,
                "headline": "Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?"
              },
              {
                "id": 141193504,
                "url": "https://finnhub.io/api/news?id=5b3bb4d9cc663d38ddfe32336318bd630e1dd2a1d756345bcc53da27d9a33d98",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 1.15% on an annualized basis producing an average annual return of 14.61%. Currently, Thermo Fisher Scientific has a market",
                "category": "company",
                "datetime": 1786464029,
                "headline": "$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today"
              },
              {
                "id": 141200940,
                "url": "https://finnhub.io/api/news?id=c44052aadf349e2b12ec9090ff46a7563b4d9e844f2a2b7110ecdc4a3ef20b18",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "WALTHAM, Mass., August 11, 2026--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the completion of Olink Explore HT proteomic analysis of approximately 5,500 research samples from The Michael J. Fox Foundation’s (MJFF) landmark study, the Parkinson’s Precision Medicine Initiative (PPMI). The resulting data are now in PPMI’s data repository, where they are available to the global research community.",
                "category": "company",
                "datetime": 1786451400,
                "headline": "Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine"
              },
              {
                "id": 141185598,
                "url": "https://finnhub.io/api/news?id=eaf94b986135df15a5e8a571e827a90f4de7c90a4feffb910cce217533b41606",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/11/Thermo-Fisher-Cambridge--Ma--Usa---June-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher expects 15-20% customer growth in India over 5 years, driven by expanding biopharma, clean energy, and tech sectors.",
                "category": "company",
                "datetime": 1786449646,
                "headline": "Thermo Fisher Says India Is One Of Its Fastest-Growing Markets"
              },
              {
                "id": 141185599,
                "url": "https://finnhub.io/api/news?id=a8042a6ebba8f62e7b01318e00d6e6784c6ae86e3738260341e6102d2b1e33b8",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/insider_trade_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "A significant insider transaction involving the exercise of company stock options was reported on August 10, by Joseph R Holmes, VP & Chief Accounting Officer at Thermo Fisher Scientific (NYSE:TMO), as per the",
                "category": "company",
                "datetime": 1786446114,
                "headline": "Witnessing An Insider Decision, Joseph R Holmes Exercises Options Valued At $120K At Thermo Fisher Scientific"
              },
              {
                "id": 141183697,
                "url": "https://finnhub.io/api/news?id=00217da81fa35aa64050e53b8d06e789d20f8f23a8ef5eab634e3d215184cfb8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The \"Non-Viral Transfection Reagents Market (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User and Geographical Regions-Trends and Forecast Till 2035\" has been added to ResearchAndMarkets.com's offering. The global non-viral transfection reagents market is projected to increase from USD 0.89 billion in 2026 to USD 2.01 billion by 2035, expanding at a compound annual growth rate of 9.5% during the forecast period. Market gr",
                "category": "company",
                "datetime": 1786437900,
                "headline": "Non-Viral Transfection Reagents Market Report (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User & Region, Featuring Bio-Rad, MaxCyte, MilliporeSigma, Thermo Fisher Scientific"
              },
              {
                "id": 141178836,
                "url": "https://finnhub.io/api/news?id=4c28520f689c26181a43865881444b641b3ecc602645653667377b4a6e0fea30",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 1% and th",
                "category": "company",
                "datetime": 1786391884,
                "headline": "Sector Update: Healthcare Stocks Gain Late Afternoon"
              },
              {
                "id": 141177593,
                "url": "https://finnhub.io/api/news?id=5673eef1b4d22935ead2b0f60b3668cc7f178414347c327699ee964157cab081",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "In late July 2026, Thermo Fisher Scientific used the ADLM conference in Anaheim to highlight new FDA-cleared diagnostic platforms, including the EXENT Solution for multiple myeloma and EliA CTD 13 Screen for systemic autoimmune connective tissue diseases, alongside expanded digital and quality-control offerings for clinical laboratories. By pairing these regulatory milestones with integrated software such as LabLink360 and broad biomarker portfolios like B·R·A·H·M·S, Thermo Fisher is...",
                "category": "company",
                "datetime": 1786389308,
                "headline": "How Investors Are Reacting To Thermo Fisher Scientific (TMO) New FDA-Cleared Multiple Myeloma Platform"
              },
              {
                "id": 141176601,
                "url": "https://finnhub.io/api/news?id=66a9761e06dd6273f6d7d67ab03fb9e01f47f3d95fee99cdac4419ac59404e4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Healthcare stocks were higher Monday afternoon, with the NYSE Healthcare Index up 0.9% and the State",
                "category": "company",
                "datetime": 1786383631,
                "headline": "Sector Update: Healthcare Stocks Rise in Afternoon Trading"
              },
              {
                "id": 141174335,
                "url": "https://finnhub.io/api/news?id=f00c9d92f620ae6ca96a4e64403ac74ee9f5cf17443c0bac58bdb1a37d370cdd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "AVAH, FDS and SHOP lead Zacks' recent standouts, with several picks posting strong gains versus the S&P 500.",
                "category": "company",
                "datetime": 1786365240,
                "headline": "Beat the Market Like Zacks: Aveanna, FactSet, Shopify in Focus"
              },
              {
                "id": 141178915,
                "url": "https://finnhub.io/api/news?id=07ea470dad8fe3cb3f82d29a00d84be13783e9346050208bb98a3a96d07eea6a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "GREENWICH, Conn., Aug. 10, 2026 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO), a leading provider of freight transportation in North America, today announced that Jonas Svedlund has joined the company as chief legal officer, effective immediately. He will lead the company’s legal and compliance functions, including corporate governance and commercial matters.Mario Harik, chairman and chief executive officer of XPO, said, “Jonas is an accomplished executive who will help advance our strategic priorities. H",
                "category": "company",
                "datetime": 1786362300,
                "headline": "XPO Appoints Jonas Svedlund as Chief Legal Officer"
              },
              {
                "id": 141170762,
                "url": "https://finnhub.io/api/news?id=6b9a3f1775af4dab94d6e3c7773120703ca790f7fe5828a80bb0233bab391613",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher Corporation (NYSE:DHR) are two of the world’s largest life sciences tools companies, making them natural competitors for investors looking to capitalize on a recovery in pharmaceutical and biotechnology research spending. Both companies delivered better-than-expected second-quarter results, but while Thermo Fisher (NYSE:TMO) raised guidance on broad-based demand improvement, Danaher’s […]",
                "category": "company",
                "datetime": 1786320091,
                "headline": "Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?"
              },
              {
                "id": 141157907,
                "url": "https://finnhub.io/api/news?id=a096396f458447a920bab41c4f6cb031f45ee83d78ac9b44c789b32bb0d1090b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2180557737/image_2180557737.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "IDEXX Labs remains a buy: durable moat, recurring revenue, raised FY26 EPS outlook, and long-term international growth. Click to see Q2 highlights & valuation.",
                "category": "company",
                "datetime": 1786176000,
                "headline": "IDEXX Laboratories: Worth The Premium"
              },
              {
                "id": 141148177,
                "url": "https://finnhub.io/api/news?id=d125aba8d6bfc00d706132d273626c8dadaedc5c85eb89d47c934fce7ab53293",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "LH shares surged 14% in a month as stronger earnings, margin gains and growth collide with a valuation above the company's five-year median.",
                "category": "company",
                "datetime": 1786113360,
                "headline": "Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation"
              },
              {
                "id": 141145346,
                "url": "https://finnhub.io/api/news?id=cd5343e74cd2a9198724b952ecebdd554898ca6db44b640a8339ed21f987aceb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global gRNA Market size & share revenue was valued at approximately USD 518 Million in 2024 and is expected to reach USD 616 Million in 2025 and is expected to reach around USD 2950 Million by 2034, at a CAGR of 19% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scientific Inc., Agilent Technolo",
                "category": "company",
                "datetime": 1786051800,
                "headline": "[Latest] Global gRNA Market Size/Share Worth USD 2950 Million by 2034 at a 19% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)"
              },
              {
                "id": 141135533,
                "url": "https://finnhub.io/api/news?id=9cb546f94b34511297f2c084b2fb2d0efcc05c53fd0cdd68ff0bd61222c83c08",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Becton Dickinson (BDX) raised its full-year earnings guidance as the medical device maker's third-qu",
                "category": "company",
                "datetime": 1786030368,
                "headline": "Becton Dickinson Lifts Full-Year Profit Outlook as Third-Quarter Results Top Views"
              },
              {
                "id": 141125770,
                "url": "https://finnhub.io/api/news?id=55c1e1297e1a43b11c8c89d701077cc78cf6f9c6a3ce44d380407b79aa4b46bf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Deep Eutectic Solvents Market size & share revenue was valued at approximately USD 177.64 Million in 2024 and is expected to reach USD 204.77 Million in 2025 and is expected to reach around USD 735.89 Million by 2034, at a CAGR of 15.27% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Proionic GmbH, Iol",
                "category": "company",
                "datetime": 1785958200,
                "headline": "[Latest] Global Deep Eutectic Solvents Market Size/Share Worth USD 735.89 Million by 2034 at a 15.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)"
              },
              {
                "id": 141122347,
                "url": "https://finnhub.io/api/news?id=46bdae6171ab25d7b8b18940c81feb4ac51e0f26d9330d5631c5e96da9e002cd",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160261210/image_2160261210.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Bruker Corporation faces ongoing headwinds from weak academic/government funding that has compressed growth. Read more on BRKR stock here.",
                "category": "company",
                "datetime": 1785931020,
                "headline": "Weak Growth In Its Primary Market Continues To Weigh Heavily On Bruker Shares"
              },
              {
                "id": 141103023,
                "url": "https://finnhub.io/api/news?id=4790310e5ed96b76e44adf51fa3aaeb1d78d172fb9afdc61e8964ee3f9c244bd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.",
                "category": "company",
                "datetime": 1785788002,
                "headline": "3 Cash-Producing Stocks We Think Twice About"
              },
              {
                "id": 141100874,
                "url": "https://finnhub.io/api/news?id=6b8be8e80249eee81328fe41d0208e0f2a4ceb16bcae0bb5c93ebaec58590848",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "TMO lifted its 2026 outlook after Q2 topped estimates, driven by stronger demand, acquisitions and margin gains. Can the momentum continue?",
                "category": "company",
                "datetime": 1785771420,
                "headline": "Thermo Fisher Raises 2026 Outlook After Strong Second-Quarter Results"
              },
              {
                "id": 141100875,
                "url": "https://finnhub.io/api/news?id=f3f4d21a89aa82427dddec50d1979ffdcf38762ace0db69ee484a8c55eb94ce4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Examine the evolution of Thermo Fisher's (TMO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.",
                "category": "company",
                "datetime": 1785762903,
                "headline": "Unlocking Thermo Fisher (TMO) International Revenues: Trends, Surprises, and Prospects"
              },
              {
                "id": 141082643,
                "url": "https://finnhub.io/api/news?id=05c7ae4fb41773fe01cf10657261a5f6e648120da088da6963ed32991c579eab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Microsoft rides AI, Copilot and Azure growth, but can expanding cloud demand and capacity challenges shape its next phase?",
                "category": "company",
                "datetime": 1785529500,
                "headline": "Top Analyst Reports for Microsoft, Palo Alto Networks & American Express"
              },
              {
                "id": 141081562,
                "url": "https://finnhub.io/api/news?id=eeedc487b5c846c46ee4f5f5e4ed1e1fb548fe5b030992c9ad5ff7877643d0a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) recently announced strong fiscal Q2 2026 results, with revenue growing 10% to $11.99 billion, GAAP diluted EPS rising 9% to $4.68, and adjusted EPS growing 13% to $6.03. The results prompted several analysts to raise their price targets, but after the post-earnings rally, investors must decide whether the recovery story […]",
                "category": "company",
                "datetime": 1785524963,
                "headline": "Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?"
              },
              {
                "id": 141079032,
                "url": "https://finnhub.io/api/news?id=37bec1425901ed97eb3b150eccb768342ed1b73f825ab5e848b348b44ed865c4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "TMO is expanding bioproduction, AI tools and clinical data capabilities, but execution will be key as competition intensifies.",
                "category": "company",
                "datetime": 1785504000,
                "headline": "How Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends"
              },
              {
                "id": 141072943,
                "url": "https://finnhub.io/api/news?id=614ba16e9f9842aff9f6e6cb5d3b9f8e0887863805ff56c40de9c0c76900f08b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) is back in focus after reporting second quarter results that exceeded market expectations, supported by broad-based demand and fresh regulatory clearances across its diagnostics portfolio. See our latest analysis for Thermo Fisher Scientific. Thermo Fisher Scientific’s recent earnings beat and steady flow of product clearances have coincided with a 30-day share price return of 15.04% and a 22.92% 90-day share price return. The 1-year total shareholder return of...",
                "category": "company",
                "datetime": 1785453054,
                "headline": "Thermo Fisher Scientific (TMO) Could Be 2% Undervalued After Q2 Earnings Beat"
              },
              {
                "id": 141069816,
                "url": "https://finnhub.io/api/news?id=26ef73af2e2d9dd54774b6b3923a4378abfc275210430118f5aef2cae852bbf6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Organic revenue still fell, yet a segment returning to growth and a raised outlook were enough to reprice the stock in a single session.",
                "category": "company",
                "datetime": 1785436199,
                "headline": "Avantor Stock Surged Because One Segment Stopped Shrinking"
              },
              {
                "id": 141068356,
                "url": "https://finnhub.io/api/news?id=9f63c88348cc7341889d66a5eff31868c7e394b9c509bf10ca5147c18a54ced7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher’s second quarter saw a notable uptick in end-market activity, propelling results above Wall Street’s expectations and leading to a positive market reaction. Management pointed to stronger demand across pharmaceutical, biotech, industrial, and diagnostics markets, with CEO Marc Casper highlighting “broad-based momentum” and “excellent execution” in core segments such as Bioproduction and Clinical Research. Newly launched high-end instruments and AI-powered software were key contribu",
                "category": "company",
                "datetime": 1785431822,
                "headline": "The Top 5 Analyst Questions From Thermo Fisher’s Q2 Earnings Call"
              },
              {
                "id": 141045284,
                "url": "https://finnhub.io/api/news?id=e230c03b4e1344ce98d6715be8d70854b2f51144a5c95c8a41454206af666ffb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Precision Diagnostics And Medicine Market size & share revenue was valued at approximately USD 147.23 Billion in 2025 and is expected to reach USD 159.66 Billion in 2026 and is expected to reach around USD 345.75 Billion by 2035, at a CAGR of 8.91% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are F. Hoff",
                "category": "company",
                "datetime": 1785259800,
                "headline": "[Latest] Global Precision Diagnostics And Medicine Market Size/Share Worth USD 345.75 Billion by 2035 at a 8.91% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"
              },
              {
                "id": 141044347,
                "url": "https://finnhub.io/api/news?id=9d1faf3fbb5f492ca7dcd5acc084c90757596bc020f0ce93a3e1de57bc03bf56",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The Association for Diagnostics & Laboratory Medicine (ADLM) is pleased to announce the recipients of its 2026 Top Corporate Supporter Award, a distinction given to companies and organizations that generously support the association through advertising, sponsorships, and exhibits. These significant contributions make it possible for ADLM to further its mission of better health for all through laboratory medicine.",
                "category": "company",
                "datetime": 1785254400,
                "headline": "ADLM announces 2026 Top Corporate Supporter Award recipients and thanks them for their essential backing"
              },
              {
                "id": 141042363,
                "url": "https://finnhub.io/api/news?id=3bfd6133afea3cd76b3c7c19bdd07dc3020ce45f695cfce7c40a19d245fba9d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Jefferies just named five U.S. dividend stocks to its exclusive Global Best Ideas list, and with the S&P 500 stretched to historically expensive valuations, the case for these high-conviction picks has never been more urgent.",
                "category": "company",
                "datetime": 1785243038,
                "headline": "Jefferies Global Best Ideas List Has 5 US Dividend Stocks With Huge Total Return Potential"
              },
              {
                "id": 141046020,
                "url": "https://finnhub.io/api/news?id=817820eb7708f1a426f5cc98eaf8f02a6ac10d6555fb01282b20a888b49dfad2",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Piper Sandler  analyst David Westenberg   maintains Thermo Fisher Scientific (NYSE:TMO) with a Neutral and raises the price target from $510 to $600.",
                "category": "company",
                "datetime": 1785159448,
                "headline": "Piper Sandler Maintains Neutral on Thermo Fisher Scientific, Raises Price Target to $600"
              },
              {
                "id": 141034599,
                "url": "https://finnhub.io/api/news?id=b434d5faeac0b5445fa56257eafccb17c6d90118a5f62fadbf1b9ac29eea1ae3",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Morgan Stanley  analyst Tejas Savant   maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $620 to $650.",
                "category": "company",
                "datetime": 1785155664,
                "headline": "Morgan Stanley Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $650"
              },
              {
                "id": 141032954,
                "url": "https://finnhub.io/api/news?id=4ad71d82f5a3da8fa9ddb3f8bf69adef6aa0a1f3ba9b2d09da9d76f1ae5c1349",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "WALTHAM, Mass., July 27, 2026--Thermo Fisher Scientific, the world leader in serving science, will showcase its latest diagnostic innovations, recent regulatory milestones and expanded capabilities at the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 26-30, 2026, in Anaheim, Calif. Spanning specialty diagnostics, quality management and the full diagnostic continuum, Thermo Fisher’s presence at ADLM 2026 reflects its ongoing commitment to addressing unmet clinical need",
                "category": "company",
                "datetime": 1785155400,
                "headline": "Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026"
              },
              {
                "id": 141032829,
                "url": "https://finnhub.io/api/news?id=e9669444eb7d54da770e3c0dfa28ef3a5858b6c67f0d7a5f6f15443a00e4cf3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "MNST, CRS and USIO highlight Zacks strategies that outperformed amid a volatile market.",
                "category": "company",
                "datetime": 1785154500,
                "headline": "Beat the Market Like Zacks: Monster Beverage, Carpenter Tech, Usio in Focus"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 62,
            "discarded_article_count": 52
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 22.5,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 2.7,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": true,
            "vcp_score": 2.7,
            "vcp_reason": "波幅收縮(24%→10.6%)；跌縮量(近10日5日)；站上MA50；升放量(近10日2日)；Ready=Y；Confirm=Y",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 2094890,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 1672210,
              "avg_vol_20": 1808735,
              "avg_vol_30": 2094890,
              "range_pct_10": 0.10572659084670935,
              "range_pct_20": 0.13662403507522256,
              "range_pct_30": 0.23979420587353187,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.798232842774561,
              "dist_to_20d_high": 0.02054092735703248,
              "down_shrink_days": 5,
              "breakout_level_20d": 647,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.44090552756086965
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.8,
            "details": {
              "atrPct": 2.50576754333157,
              "turnoverUsdM": 1167.6677457518,
              "liquidityPoints": 0.8,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.TMO",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 601.9514,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 5,
            "take_profit_price": 670.9205,
            "target_multiplier": 1.9,
            "technical_strength": 1.85,
            "take_profit_percent": 5.9
          },
          "positionPoints": 1.8,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.01153508666314,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 71.43,
    "atr": {
      "atr": 15.8793,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.51
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 128.94
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "強累積",
      "score": 10,
      "value": 0.4162
    },
    "kdj": {
      "d": 78.92,
      "j": 81.32,
      "k": 79.72,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 64.99
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 19597490,
      "recentSlope": 517019,
      "previousSlope": 37400
    },
    "rsi": 78.28,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 609.6329,
      "position": "SAR喺價下",
      "distancePct": 3.8,
      "previousTrend": "上升"
    },
    "ma50": 551.1138,
    "macd": {
      "macd": 22.044539380633182,
      "trend": "強烈看漲",
      "signal": 20.512025150079843,
      "histogram": 1.532514230553339
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 597.1282,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 41
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.04,
      "score": 6,
      "avgVolume": 1773525,
      "currentVolume": 1842590
    },
    "derived": {
      "ma20": 598.4545,
      "ma50": 551.1138,
      "prevClose": 628.15,
      "avgVolume10": 1703309,
      "avgVolume20": 1773525,
      "changePercent": 0.89,
      "avgVolumeForScore": 1773525
    },
    "ma_cross": {
      "ma20": 598.4545,
      "ma50": 551.1138,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 595.592,
      "prevMa50": 547.914,
      "spreadPct": 8.59,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 555.8677,
      "upper": 641.0413,
      "position": "上半部"
    },
    "rsi_short": 97.61,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.04
    }
  }
}

{
  "close": 633.71,
  "volume": 1842590,
  "changePercent": 0.89
}